Endosomal Escape Enhancing Compounds Facilitate Functional Delivery of Extracellular Vesicle Cargo

Nikki Heath(AstraZeneca (United Kingdom)), Xabier Osteikoetxea(AstraZeneca (United Kingdom)), Taiana Mia de Oliveria, Elisa Lázaro‐Ibáñez(AstraZeneca (Australia)), Olga Shatnyeva(AstraZeneca (Australia)), Christina Schindler(AstraZeneca (Germany)), Natalie J. Tigue(AstraZeneca (Germany)), Lorenz M. Mayr(General Electric (Spain)), Niek Dekker(AstraZeneca (Australia)), R. Overman(AstraZeneca (United Kingdom)), Rick Davies(AstraZeneca (United Kingdom))
Nanomedicine
November 1, 2019
Cited by 81Open Access
Full Text

Abstract

Aim: Extracellular vesicles (EVs) are desirable delivery vehicles for therapeutic cargoes. We aimed to load EVs with Cre recombinase protein and determine whether functional delivery to cells could be improved by using endosomal escape enhancing compounds. Materials & methods: Overexpressed CreFRB protein was actively loaded into EVs by rapalog-induced dimerization to CD81FKBP, or passively loaded by overexpression in the absence of rapalog. Functional delivery of CreFRB was analysed using a HEK293 Cre reporter cell line in the absence and presence of endosomal escape enhancing compounds. Results: The EVs loaded with CreFRB by both active and passive mechanisms were able to deliver functional CreFRB to recipient cells only in the presence of endosomal escape enhancing compounds chloroquine and UNC10217938A. Conclusion: The use of endosomal escape enhancing compounds in conjunction with EVs loaded with therapeutic cargoes may improve efficacy of future EV based therapeutics.


Related Papers

No related papers found

Powered by citation graph analysis